Metabolic Messengers: oestradiol

Area of Science:

• Endocrinology
• Metabolic research
• Molecular biology

Background:

• Oestradiol (E2) is a key steroid hormone in female reproduction and menopause.
• Emerging evidence highlights E2's critical role in regulating systemic metabolism in both women and men.
• Oestrogen receptor alpha (encoded by ESR1) mediates many of E2's metabolic actions.

Purpose of the Study:

• To provide an overview of E2's cell-specific actions in modulating metabolic pathways.
• To link preclinical mechanistic studies with epidemiological data on menopause and metabolic disease.
• To present evidence for E2 replacement therapy in preserving metabolic health.

Main Methods:

• Review of cell-specific actions of E2 and its receptors (alpha and beta) on metabolic pathways.
• Contextualization of preclinical findings with epidemiological data.
• Analysis of evidence for E2 replacement therapy's impact on metabolic health.

Main Results:

• E2 plays a significant role in regulating systemic metabolism in both sexes.
• Oestrogen receptor alpha expression patterns correlate with metabolic health indices.
• The menopausal transition is linked to increased metabolic disease risk.
• E2 replacement may preserve metabolic health and mitigate disease risk.

Conclusions:

• E2 is a crucial regulator of systemic metabolism, acting through its receptors.
• Menopause-associated metabolic decline can be potentially addressed by E2 replacement therapy.
• Further research into E2's metabolic actions is warranted for therapeutic strategies.